Need help? Email us and our team of experts will reply [email protected]

 
 
GLP-2

GLP-2

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

Certificate of Analysis

Third-party tested for endotoxins

View COA Document 1
View COA Document 2
View COA Document 1
View COA Document 2
10 mg

Synthetic lipidated peptide, 39 residues, C-terminal amide. Reference material for in vitro laboratory research use only.

CAS 2023788-19-2
Sequence 39 residues, lipidated; see lot Certificate of Analysis
Molecular formula C225H348N48O68
Molecular weight 4813.5 g/mol
Net content 10 mg per vial (gross fill; actual content per lot COA)
Form Lyophilized powder
Storage ?20 °C, desiccated, protected from light and moisture
Testing Identity and purity verified by third-party HPLC analysis; a lot-specific Certificate of Analysis is provided with each order.

Research Use Only. Not a drug, supplement, or food. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

GLP-2 Structure

CAS: 2023788-19-2
Sequence 39 residues, lipidated; see lot Certificate of Analysis
Molecular formula C225H348N48O68
Molecular weight 4813.5 g/mol

Research Findings

GLP-2 has been investigated primarily for its involvement in gastrointestinal and intestinal signaling.

Key Areas of Research:

  • Intestinal Signaling: Investigation of GLP-2 receptor-mediated signaling in intestinal tissues
  • Epithelial Biology: Research into intestinal epithelial cell proliferation, survival, and related cellular processes
  • Gastrointestinal Function: Study of GLP-2 signaling in gastrointestinal physiology
  • Nutrient Handling: Investigation of pathways associated with intestinal nutrient absorption and transport
  • Cellular Signaling: Research into downstream pathways activated by the GLP-2 receptor

GLP-2 therefore provides a research model for studying peptide-receptor signaling and the biological processes associated with intestinal physiology.

IUPHAR/BPS Guide to PHARMACOLOGY

References

IUPHAR/BPS Guide to PHARMACOLOGY — Human GLP-2

Bio-Techne/Tocris — GLP-2 (human)

U.S. FDA Substance Registration System — Glucagon-like Peptide II

Rocha et al. — Glucagon-like peptide-2: divergent signalling pathways

Brubaker & Drucker — Glucagon-like peptides and cellular signaling

Our Process

View Products

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

STEP 1

Precision Lyophilization

Manufactured in a controlled U.S. facility under strict compounding standards.

STEP 2

Verified Purity

Every batch third-party tested with HPLC and mass spectrometry.

STEP 3

Same-Day Fulfillment

Orders dispatched same-day from our
U.S. facility.

Email us, our dedicated team is here to help

Reach out and get a response within minutes.

Email Us

Frequently Asked Questions

Everything you need to know about our products and processes.

View Products

Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.

 
Peptides are supplied as lyophilized powder. They do not come reconstituted, and any extra supplies must be sourced separately for research applications.
 
 
In lyophilized powder form, peptides stay stable for up to 2 years. After reconstitution, it should be refrigerated and is generally stable for up to 2 months.
 
 
Products from us do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
 
 
Lyophilized peptides should be stored away from heat and light. Once reconstituted, they must be refrigerated to maintain stability and efficacy.